Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ratner

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Leukemia Research|February 14, 2012
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and SmacSampath Ramachandiran, Joan Cain, Albert Liao, et al.
Retrovirology|December 23, 2019
HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivoMichael P Martinez, Xiaogang Cheng, Ancy Joseph, et al.
Leukemia Research|October 11, 2025
Corrigendum to "The SMAC mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and SMAC" [Leuk. Res., 36(2011) 784-90]Sampath Ramachandiran, Joan Cain, Albert Liao, et al.
Retrovirology|April 26, 2012
Vpx is critical for SIVmne infection of pigtail macaquesMichael Belshan, Jason T Kimata, Charles Brown, et al.
Scientific Reports|August 9, 2017
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activationBrice J Albert, Austin Niu, Rashmi Ramani, et al.
Retrovirology|February 25, 2014
Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, CanadaBenoit Barbeau, John Hiscott, Ali Bazarbachi, et al.
The Oncologist|April 16, 2022
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) StudyMissak Haigentz, Page Moore, Milan Bimali, et al.
The Journal of Biological Chemistry|March 16, 2018
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemiaMathew A Cherian, Sydney Olson, Hemalatha Sundaramoorthi, et al.
Plos Pathogens|April 1, 2025
Single-Cell Transcriptomic Analysis of Kaposi SarcomaDaniel A Rauch, Paula Valiño Ramos, Mariam Khanfar, et al.
Plos Pathogens|March 17, 2015
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signalingRajeshree Pujari, Richard Hunte, Remy Thomas, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Leukemia Research|February 14, 2012
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and SmacSampath Ramachandiran, Joan Cain, Albert Liao, et al.
Retrovirology|December 23, 2019
HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivoMichael P Martinez, Xiaogang Cheng, Ancy Joseph, et al.
Leukemia Research|October 11, 2025
Corrigendum to "The SMAC mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and SMAC" [Leuk. Res., 36(2011) 784-90]Sampath Ramachandiran, Joan Cain, Albert Liao, et al.
Retrovirology|April 26, 2012
Vpx is critical for SIVmne infection of pigtail macaquesMichael Belshan, Jason T Kimata, Charles Brown, et al.
Scientific Reports|August 9, 2017
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activationBrice J Albert, Austin Niu, Rashmi Ramani, et al.
Retrovirology|February 25, 2014
Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, CanadaBenoit Barbeau, John Hiscott, Ali Bazarbachi, et al.
The Oncologist|April 16, 2022
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) StudyMissak Haigentz, Page Moore, Milan Bimali, et al.
The Journal of Biological Chemistry|March 16, 2018
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemiaMathew A Cherian, Sydney Olson, Hemalatha Sundaramoorthi, et al.
Plos Pathogens|April 1, 2025
Single-Cell Transcriptomic Analysis of Kaposi SarcomaDaniel A Rauch, Paula Valiño Ramos, Mariam Khanfar, et al.
Plos Pathogens|March 17, 2015
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signalingRajeshree Pujari, Richard Hunte, Remy Thomas, et al.
Pageof 15